Cargando…
Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease
Human pluripotent stem cells (PSC) have the potential to revolutionize regenerative medicine. However undifferentiated PSC can form tumors and strict quality control measures and safety studies must be conducted before clinical translation. Here we describe preclinical tumorigenicity and biodistribu...
Autores principales: | Garitaonandia, Ibon, Gonzalez, Rodolfo, Christiansen-Weber, Trudy, Abramihina, Tatiana, Poustovoitov, Maxim, Noskov, Alexander, Sherman, Glenn, Semechkin, Andrey, Snyder, Evan, Kern, Russell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055076/ https://www.ncbi.nlm.nih.gov/pubmed/27686862 http://dx.doi.org/10.1038/srep34478 |
Ejemplares similares
-
Deriving dopaminergic neurons for clinical use. A practical approach
por: Gonzalez, Rodolfo, et al.
Publicado: (2013) -
Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model
por: Lee, Jea-Young, et al.
Publicado: (2019) -
Molecular Imaging of Stem Cells: Tracking Survival, Biodistribution, Tumorigenicity, and Immunogenicity
por: Gu, Eugene, et al.
Publicado: (2012) -
Non-clinical assessment of safety, biodistribution and tumorigenicity of human mesenchymal stromal cells
por: Thäte, Claudia, et al.
Publicado: (2021) -
Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP)
por: Zscharnack, Matthias, et al.
Publicado: (2015)